ALSEN - Watch out pullback vs fall UT WeeklyBelow SMA200 so risky to play a rise, but above SMA50 which is so far a good support.
We are at a critical point, either we see a pullback soon, and it can go up back to 2.2 meaning 50% profit
OR the SMA50 breaks, giving a sell signal.
The buy signal is if the stock closed above the SMA20 end of th
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.0935 EUR
−25.97 M EUR
0.00 EUR
148.79 M
About Sensorion SAS
Sector
Industry
CEO
Nawal Ouzren
Website
Headquarters
Montpellier
Founded
2009
Identifiers
2
ISIN FR0012596468
Sensorion SA is a biopharmaceutical company, which engages in the development of therapies to treat and prevent diseases of the inner ear such as deafness, vertigo, and tinnitus. The company was founded by Christian Chabbert, Gilles Desmadryl, Sylvain Bartolami and Sophie Gaboyard in 2009 and is headquartered in Montpellier, France.
Related stocks
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange Sensorion SAS stocks are traded under the ticker RFM.
We've gathered analysts' opinions on Sensorion SAS future price: according to them, RFM price has a max estimate of 4.00 EUR and a min estimate of 1.00 EUR. Watch RFM chart and read a more detailed Sensorion SAS stock forecast: see what analysts think of Sensorion SAS and suggest that you do with its stocks.
Yes, you can track Sensorion SAS financials in yearly and quarterly reports right on TradingView.
Sensorion SAS is going to release the next earnings report on Mar 12, 2026. Keep track of upcoming events with our Earnings Calendar.
RFM earnings for the last half-year are −0.05 EUR per share, whereas the estimation was −0.05 EUR, resulting in a 0.00% surprise. The estimated earnings for the next half-year are −0.06 EUR per share. See more details about Sensorion SAS earnings.
Sensorion SAS revenue for the last half-year amounts to 2.33 M EUR, despite the estimated figure of 3.31 M EUR. In the next half-year revenue is expected to reach 2.85 M EUR.
RFM net income for the last half-year is −16.01 M EUR, while the previous report showed −12.08 M EUR of net income which accounts for −32.55% change. Track more Sensorion SAS financial stats to get the full picture.
No, RFM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jan 21, 2026, the company has 63 employees. See our rating of the largest employees — is Sensorion SAS on this list?
Like other stocks, RFM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Sensorion SAS stock right from TradingView charts — choose your broker and connect to your account.


